Cellular functions of programmed cell death 5

被引:43
|
作者
Li, Ge [1 ,2 ]
Ma, Dalong [1 ,2 ]
Chen, Yingyu [1 ,2 ]
机构
[1] Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xueyuan Rd, Beijing 100191, Peoples R China
[2] Peking Univ, Ctr Human Dis Genom, 38 Xueyuan Rd, Beijing 100191, Peoples R China
来源
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Programmed cell death 5; PDCD5; Apoptosis; Tumor; Immune regulation; Autoimmune diseases; CISPLATIN-INDUCED APOPTOSIS; HUMAN PDCD5 RHPDCD5; IN-VITRO; PROGNOSTIC-SIGNIFICANCE; CLINICAL-SIGNIFICANCE; REGULATING AUTOPHAGY; CELL-DEATH-5; PROTEIN; DISEASE-ACTIVITY; SYNOVIAL-FLUID; CANCER CELLS;
D O I
10.1016/j.bbamcr.2015.12.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Programmed cell death 5 (PDCD5) was originally identified as an apoptosis-accelerating protein that is widely expressed and has been well conserved during the process of evolution. PDCD5 has complex biological functions, including programmed cell death and immune regulation. It can accelerate apoptosis in different type of cells in response to different stimuli. During this process, PDCD5 rapidly translocates from the cytoplasm to the nucleus. PDCD5 regulates the activities of TIP60, HDAC3, MDM2 and TP53 transcription factors. These proteins form part of a signaling network that is disrupted in most, if not all, cancer cells. Recent evidence suggests that PDCD5 participates in immune regulation by promoting regulatory T cell function via the PDCD5-TIP60-FOXP3 pathway. The stability and expression of PDCD5 are finely regulated by other molecules, such as NF-kappa B p65, OTUD5, YAF2 and DNAJB1. PDCD5 is phosphorylated by CK2 at Ser119, which is required for nuclear translocation in response to genotoxic stress. In this review, we describe what is known about PDCD5 and its cellular functions. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:572 / 580
页数:9
相关论文
共 50 条
  • [41] Programmed cell death in aging
    Tower, John
    AGEING RESEARCH REVIEWS, 2015, 23 : 90 - 100
  • [42] Programmed Cell Death in Cystinosis
    Ames, Elizabeth G.
    Thoene, Jess G.
    CELLS, 2022, 11 (04)
  • [43] Apoptosis or programmed cell death
    Nyongo, A
    EAST AFRICAN MEDICAL JOURNAL, 1997, 74 (02) : 61 - 61
  • [44] PROGRAMMED CELL-DEATH
    LYNCH, JW
    CANCER RESEARCH THERAPY & CONTROL, 1993, 3 (03): : 213 - 219
  • [45] Programmed cell death lives
    Arjan W. Griffioen
    Patrycja Nowak-Sliwinska
    Apoptosis, 2022, 27 : 619 - 621
  • [46] Disturbing the Programmed Cell Death
    van den Bergh, Walter M.
    CRITICAL CARE MEDICINE, 2013, 41 (09) : 2250 - 2251
  • [47] POLYAMINES AND PROGRAMMED CELL DEATH
    Chojnacka, Agnieszka
    Sobieszczuk-Nowicka, Ewa
    POSTEPY BIOLOGII KOMORKI, 2009, 36 (02) : 161 - 169
  • [48] Programmed cell death and cancer
    Sun, Y.
    Peng, Z-L
    POSTGRADUATE MEDICAL JOURNAL, 2009, 85 (1001) : 134 - 140
  • [49] Erythrocyte programmed cell death
    Foeller, Michael
    Huber, Stephan M.
    Lang, Florian
    IUBMB LIFE, 2008, 60 (10) : 661 - 668
  • [50] The machinery of programmed cell death
    Zimmermann, KC
    Bonzon, C
    Green, DR
    PHARMACOLOGY & THERAPEUTICS, 2001, 92 (01) : 57 - 70